Moreno, C., Aiello, A., Di Virgilio, R., Mazzotta, V., & Antinori, A. (2025). Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19. Global and Regional Health Technology Assessment, 11(1), 168–176. https://doi.org/10.33393/grhta.2024.3403